Glaxo confirms Omega-3 row is over

30th Mar 2011 07:44

UK drugs giant GlaxoSmithKline today confirmed that a legal spat over the US patent for Omega-3 drug Lovaza has been settled.Pronova BioPharma Norge AS, which owns the patents for Lovaza, has agreed to let Apotex launch a generic version in the US in the first quarter of 2015, or earlier, "depending on certain circumstances".Glaxo owns the marketing rights for Lovaza in the US and Puerto Rico and last year collected £530m of revenue from the drug.Other terms of the settlement are confidential. Pronova's lawsuit with Teva Pharmaceuticals USA, Inc., and Par Pharmaceutical, Inc., regarding Lovaza patents are ongoing.LW

Top Risers

Share	Price	Change
Huddled Group (HUD)	0.85	24.14%
Eurasia Mining (EUA)	2.80	19.15%
Genincode (GENI)	0.725	16%
Medpal AI (MPAL)	5.25	14.13%
Light Science Technologies (LST)	0.875	12.9%

Top Fallers

Share	Price	Change
Catenai Plc (CTAI)	0.0575	-39.47%
Petra Diamonds (PDL)	2.60	-26.14%
Focus Xplore (FOX)	0.019	-22.45%
Litigation Cap. (LIT)	0.301	-20.12%
Abrdn Property (API)	1.52	-15.56%

Top By Volume

Share	Price	Volume
Ethernity Net (ENET)	0.0019	1,922,336,250
Forgent (FORG)	0.0115	591,087,829
Premier African Minerals (PREM)	0.0044	313,776,718
Focus Xplore (FOX)	0.019	253,421,870
Bezant Resources PLC (BZT)	0.11	246,929,868

All prices are delayed by at least 15 minutes. Share Compare cannot be held responsible for the accuracy of share prices shown on this website, and investors should be aware that share prices can go down as well as up. Share Compare does not offer advice, and is not regulated by the Financial Conduct Authority.